6:27 PM
Apr 19, 2010
 |  BC Extra  |  Company News

Novartis pulls Joulferon MAA

Novartis AG (NYSE:NVS; SIX:NOVN) withdrew an MAA for Joulferon albinterferon alfa-2b to treat chronic HCV after the European Medicines Agency (EMA) requested additional data that will...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >